Last week, readers were most interested in a story about Roche gaining FDA clearance and CLIA waiver for its STI point-of-care test.
The finalized local coverage determinations were set to go into effect on Feb. 23 but have been pushed back two months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback